Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570784
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey PlayersDalarna County Council, SwedenNot Yet Recruiting
NCT07570784Not Yet Recruiting
—
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Fe...Dalarna County Council, S...
NCT07569354
Recovery Among Older Adults Following Mild TBINational Institute on Aging (NIA)Recruiting
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07569341
Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal MetastasesLinkoeping UniversityCompleted
NCT07569341Completed
—
Validation of the Classification for Resectability and Ablatability Criteria for...Linkoeping University
NCT07571408
Intraoperative Application of Cold Atmospheric Plasma to Prevent Postoperative Wound Complications in the Inguinal Region of High-risk Patients With Peripheral Arterial Occlusive Diseaseneoplas med GmbHNot Yet RecruitingNot Applicable
NCT07571408Not Yet Recruiting
Not Applicable
Intraoperative Application of Cold Atmospheric Plasma to Prevent Postoperative W...neoplas med GmbH
NCT07570563
Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.Chinese PLA General HospitalRecruitingPhase 1
NCT07570563Recruiting
Phase 1
Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Maligna...Chinese PLA General Hospi...
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570004
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu OzkanCompletedNot Applicable
NCT07570004Completed
Not Applicable
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu Ozkan
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07571512
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Knee Arthroplasty for the Study of Innovative Solutions in the Treatment of Joint and Ligament PathologiesStefano ZaffagniniCompleted
NCT07571512Completed
—
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Kn...Stefano Zaffagnini
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571343
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of WisconsinNot Yet RecruitingNot Applicable
NCT07571343Not Yet Recruiting
Not Applicable
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of Wiscon...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07570290
Comparison of Artificial Intelligence and Clinicians With Different Experience Levels in Assessing Gingival PhenotypeOndokuz Mayıs UniversityNot Yet Recruiting
NCT07570290Not Yet Recruiting
—
Comparison of Artificial Intelligence and Clinicians With Different Experience L...Ondokuz Mayıs University
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Completed4 (20%)
Not Specified9 (45%)
not_applicable5 (25%)
Phase 14 (20%)
Phase 41 (5%)
Phase 21 (5%)